REFERENCES
- Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984; 132: 474–479.
- Brodie AMH, Son C, King DA, Meyer DA, Inkster SE. Lack of evidence for aromatase in human prostatic tissues: Effects of 4-hydroxyandrostenedione and other inhibitors on androgen metabolism. Cancer Res 1989; 49: 6551–6555.
- Drafta D, Proca E, Zamfir V, Schindler AE, Neacsu E, Stroe E. Plasma steroids in benign prostatic hypertrophy and carcinoma of the prostate. J steroid Biochem 1982; 17: 689–693.
- Ekman P, Brolin J. Steroid receptor profile in human prostate cancer metastases as compared with primary prostatic carcinoma. The Prostate 1991; 18: 147–153.
- Imai K, S Zinbo, Shimizu K, Yamanaka H, Kumasaka F, Sato Z. Clinical characteristics of prostate cancer detected by mass screening. The Prostate 1988; 12: 199–207.
- Kaburagi Y, Marino MB, Kirdani RY, Greco JP, Karr JP, Sandberg AA. The possibility of aromatization of androgen in human prostate. J steroid Biochem 1987; 26: 739–742.
- Mobbs BG, Johnson IE, Liu Y. Quantitation of cytosolic and nuclear estrogen and progesterone receptor in benign, untreated, and treated malignant human prostatic tissue by radioligand binding and enzyme-immunoassays. The Prostate 1990; 16: 235–244.
- Partin AW, Oesterling JE, Epstein JI, Horton R, Walsh PC. Influence of age and endocrine factors on the volume of benign prostatic hyperplasia. J Urol 1991; 145: 405–409.
- Peters CA, Walsh PC. The effect of nafarelin acetate, a luteinizing-hormone-releasing hormone agonist, on benign prostatic hyperplasia. N Engl J Med 1987; 317: 599–603.
- Rannikko S, Adlercreutz H. Plasma estradiol, free testosterone, sex hormone binding globulin binding capacity, and prolactin in benign prostatic hyperplasia and prostatic cancer. The Prostate 1983; 4: 223–229.
- Seppelt U. Correlation among prostate stroma, plasma estrogen levels, and urinary estrogen excretion in patients with benign prostatic hypertrophy. J Clin Endocrinol Metab 1978; 47: 1230–1235.
- Suzuki K, Inaba S, Takeuchi H, Takezawa Y, Fukabori Y, Suzuki T, Imai K, Yamanaka H, Honma S. Endocrine environment of benign prostatic hyperplasia. Jpn J Urol 1992; 83: 664–671.
- Trachtenberg J, Hicks LL, Walsh PC. Androgen-and estrogen-receptor content in spontaneous and experimentally induced canine prostate hyperplasia. J Clin Invest 1980; 65: 1051–1059.